Predictors of Reperfusion in Patients with Acute Ischemic Stroke

References

1. 1.↵
   2. Hacke W,
   3. Donnan G,
   4. Fieschi C, et al

   . Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004;363:768–74

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Wintermark M,
   3. Albers GW,
   4. Broderick JP, et al

   ; for the Stroke Imaging Research (STIR) and Virtual International Stroke Trials Archive (VISTA)-Imaging Investigators. Acute Stroke Imaging Research Roadmap II. Stroke 2013;44:2628–39

   FREE Full Text
3. 3.↵
   2. Dalkara T,
   3. Arsava EM

   . Can restoring incomplete microcirculatory reperfusion improve stroke outcome after thrombolysis? J Cereb Blood Flow Metab 2012;32:2091–99

   CrossRefPubMed
4. 4.↵
   2. Zaidat OO,
   3. Yoo AJ,
   4. Khatri P, et al

   . Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke 2013;44:2650–63

   FREE Full Text
5. 5.↵
   2. Soares BP,
   3. Tong E,
   4. Hom J, et al

   . Reperfusion is a more accurate predictor of follow-up infarct volume than recanalization: a proof of concept using CT in acute ischemic stroke patients. Stroke 2010;41:e34–40

   Abstract/FREE Full Text
6. 6.↵
   2. Albers GW,
   3. Thijs VN,
   4. Wechsler L, et al

   . Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006;60:508–17

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Murphy A,
   3. Symons SP,
   4. Hopyan J, et al

   . Factors influencing clinically meaningful recanalization after IV-rtPA in acute ischemic stroke. AJNR Am J Neuroradiol 2013;34:146–52

   Abstract/FREE Full Text
8. 8.↵
   2. Furlan AJ,
   3. Eyding D,
   4. Albers GW, et al

   . Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006;37:1227–31

   Abstract/FREE Full Text
9. 9.↵
   2. Hacke W,
   3. Albers G,
   4. Al-Rawi Y, et al

   . The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:66–73

   Abstract/FREE Full Text
10. 10.↵
    2. Fiehler J,
    3. Remmele C,
    4. Kucinski T, et al

    . Reperfusion after severe local perfusion deficit precedes hemorrhagic transformation: an MRI study in acute stroke patients. Cerebrovasc Dis 2005;19:117–24

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Eilaghi A,
    3. Brooks J,
    4. d'Esterre C, et al

    . Reperfusion is a stronger predictor of good clinical outcome than recanalization in ischemic stroke. Radiology 2013;269:240–48

    CrossRefPubMedWeb of Science
12. 12.↵
    2. De Silva DA,
    3. Fink JN,
    4. Christensen S, et al

    . Assessing reperfusion and recanalization as markers of clinical outcomes after intravenous thrombolysis in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET). Stroke 2009;40:2872–74

    Abstract/FREE Full Text
13. 13.↵
    2. Yoo AJ,
    3. Chandra RV,
    4. Lev MH

    . Revascularization grading: the devil is in the details. Radiology 2013;269:6–7

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Soares BP,
    3. Chien JD,
    4. Wintermark M

    . MR and CT monitoring of recanalization, reperfusion, and penumbra salvage: everything that recanalizes does not necessarily reperfuse! Stroke 2009;40:S24–27

    Abstract/FREE Full Text
15. 15.↵
    2. Davis SM,
    3. Donnan GA,
    4. Parsons MW, et al

    . Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008;7:299–309

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Derex L,
    3. Nighoghossian N,
    4. Hermier M, et al

    . Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator. J Neurol Sci 2004;225:3–9

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Parsons M,
    3. Spratt N,
    4. Bivard A, et al

    . A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med 2012;366:1099–107

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Ogata T,
    3. Christensen S,
    4. Nagakane Y, et al

    . The effects of alteplase 3 to 6 hours after stroke in the EPITHET-DEFUSE combined dataset: post hoc case-control study. Stroke 2013;44:87–93

    Abstract/FREE Full Text
19. 19.↵
    2. Olivot JM,
    3. Mlynash M,
    4. Thijs VN, et al

    . Geography, structure, and evolution of diffusion and perfusion lesions in Diffusion and perfusion imaging Evaluation For Understanding Stroke Evolution (DEFUSE). Stroke 2009;40:3245–51

    Abstract/FREE Full Text
20. 20.↵
    2. van Seeters T,
    3. Biessels GJ,
    4. van der Schaaf IC, et al

    . Prediction of outcome in patients with suspected acute ischaemic stroke with CT perfusion and CT angiography: the Dutch Acute Stroke Trial (DUST) study protocol. BMC Neurol 2014;14:37

    CrossRefPubMed
21. 21.↵
    2. Barber PA,
    3. Demchuk AM,
    4. Zhang J, et al

    . Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Lancet 2000;355:1670–74

    CrossRefPubMedWeb of Science
22. 22.↵
    2. Niesten JM,
    3. van der Schaaf IC,
    4. Riordan AJ, et al

    . Optimisation of vascular input and output functions in CT-perfusion imaging using 256 (or more)-slice multidetector CT. Eur Radiol 2013;23:1242–49

    CrossRefPubMed
23. 23.↵
    2. Wintermark M,
    3. Flanders AE,
    4. Velthuis B, et al

    . Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke. Stroke 2006;37:979–85

    Abstract/FREE Full Text
24. 24.↵
    2. Tan IYL,
    3. Demchuk AM,
    4. Hopyan J, et al

    . CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct. AJNR Am J Neuroradiol 2009;30:525–31

    Abstract/FREE Full Text
25. 25.↵
    2. Tan JC,
    3. Dillon WP,
    4. Liu S, et al

    . Systematic comparison of perfusion-CT and CT-angiography in acute stroke patients. Ann Neurol 2007;61:533–43

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Puetz V,
    3. Dzialowski I,
    4. Hill MD, et al

    . Intracranial thrombus extent predicts clinical outcome, final infarct size and hemorrhagic transformation in ischemic stroke: the clot burden score. Int J Stroke 2008;3:230–36

    CrossRefPubMedWeb of Science
27. 27.↵
    2. El-Mitwalli A,
    3. Saad M,
    4. Christou I, et al

    . Clinical and sonographic patterns of tandem internal carotid artery/middle cerebral artery occlusion in tissue plasminogen activator-treated patients. Stroke 2002;33:99–102

    Abstract/FREE Full Text
28. 28.↵
    2. Molina CA,
    3. Alvarez-Sabin J

    . Recanalization and reperfusion therapies for acute ischemic stroke. Cerebrovasc Dis 2009;27(suppl 1):162–67

    CrossRefPubMed
29. 29.↵
    2. del Zoppo GJ

    . Virchow's triad: the vascular basis of cerebral injury. Rev Neurol Dis 2008;5(suppl 1):S12–21

    PubMed
30. 30.↵
    2. Wong CH,
    3. Crack PJ

    . Modulation of neuro-inflammation and vascular response by oxidative stress following cerebral ischemia-reperfusion injury. Curr Med Chem 2008;15:1–14

    CrossRefPubMed
31. 31.↵
    2. Mendonça N,
    3. Rodriguez-Luna D,
    4. Rubiera M, et al

    . Predictors of tissue-type plasminogen activator nonresponders according to location of vessel occlusion. Stroke 2012;43:417–21

    Abstract/FREE Full Text
32. 32.↵
    2. Bhatia R,
    3. Hill MD,
    4. Shobha N, et al

    . Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke 2010;41:2254–58

    Abstract/FREE Full Text
33. 33.↵
    2. Yeo LL,
    3. Paliwal P,
    4. Teoh HL, et al

    . Timing of recanalization after intravenous thrombolysis and functional outcomes after acute ischemic stroke. JAMA Neurol 2013;70:353–58

    CrossRefPubMedWeb of Science
34. 34.↵
    2. Lemmens R,
    3. Mlynash M,
    4. Straka M, et al

    . Comparison of the response to endovascular reperfusion in relation to site of arterial occlusion. Neurology 2013;81:614–18

    CrossRef
35. 35.↵
    2. Kappelhof M,
    3. Marquering HA,
    4. Berkhemer OA, et al

    . Intra-arterial treatment of patients with acute ischemic stroke and internal carotid artery occlusion: a literature review. J Neurointerv Surg 2015;7:8–15

    Abstract/FREE Full Text
36. 36.↵
    2. Marks MP,
    3. Olivot JM,
    4. Kemp S, et al

    . Patients with acute stroke treated with intravenous tPA 3–6 hours after stroke onset: correlations between MR angiography findings and perfusion- and diffusion-weighted imaging in the DEFUSE study. Radiology 2008;249:614–23

    CrossRefPubMedWeb of Science
37. 37.↵
    2. Lansberg MG,
    3. Thijs VN,
    4. Bammer R, et al

    . The MRA-DWI mismatch identifies patients with stroke who are likely to benefit from reperfusion. Stroke 2008;39:2491–96

    Abstract/FREE Full Text
38. 38.↵
    2. Christoforidis GA,
    3. Mohammad Y,
    4. Kehagias D, et al

    . Angiographic assessment of pial collaterals as a prognostic indicator following intra-arterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 2005;26:1789–97

    Abstract/FREE Full Text
39. 39.↵
    2. Shhadeh A,
    3. Garg A,
    4. Hassan AE, et al

    . Recanalization following various endovascular modalities for treatment of anterior circulation acute ischemic strokes. J Vasc Interv Neurol 2012;5:10–16

    PubMed
40. 40.↵
    2. Tandberg Askevold E,
    3. Naess H,
    4. Thomassen L

    . Predictors for recanalization after intravenous thrombolysis in acute ischemic stroke. J Stroke Cerebrovasc Dis 2007;16:21–24

    CrossRefPubMed
41. 41.↵
    2. Saqqur M,
    3. Uchino K,
    4. Demchuk AM, et al

    . Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007;38:948–54

    Abstract/FREE Full Text
42. 42.↵
    2. Legrand L,
    3. Naggara O,
    4. Turc G, et al

    . Clot burden score on admission T2*-MRI predicts recanalization in acute stroke. Stroke 2013;44:1878–84

    Abstract/FREE Full Text
43. 43.↵
    2. Nam HS,
    3. Kim EY,
    4. Kim SH, et al

    . Prediction of thrombus resolution after intravenous thrombolysis assessed by CT-based thrombus imaging. Thromb Haemost 2012;107:786–94

    CrossRefPubMed
44. 44.↵
    2. Zangerle A,
    3. Kiechl S,
    4. Spiegel M, et al

    . Recanalization after thrombolysis in stroke patients: predictors and prognostic implications. Neurology 2007;68:39–44

    CrossRef
45. 45.↵
    2. Nambiar V,
    3. Sohn SI,
    4. Almekhlafi MA, et al

    . CTA collateral status and response to recanalization in patients with acute ischemic stroke. AJNR Am J Neuroradiol 2014;35:884–90

    Abstract/FREE Full Text
46. 46.↵
    2. Bivard A,
    3. Spratt N,
    4. Levi C, et al

    . Perfusion computer tomography: imaging and clinical validation in acute ischaemic stroke. Brain 2011;134:3408–16

    Abstract/FREE Full Text
47. 47.↵
    2. Kloska SP,
    3. Dittrich R,
    4. Fischer T, et al

    . Perfusion CT in acute stroke: prediction of vessel recanalization and clinical outcome in intravenous thrombolytic therapy. Eur Radiol 2007;17:2491–98

    CrossRefPubMed
48. 48.↵
    2. Olivot JM,
    3. Mlynash M,
    4. Thijs VN, et al

    . Relationships between cerebral perfusion and reversibility of acute diffusion lesions in DEFUSE: insights from RADAR. Stroke 2009;40:1692–97

    Abstract/FREE Full Text
49. 49.↵
    2. Luby M,
    3. Ku KD,
    4. Latour LL, et al

    . Visual perfusion-diffusion mismatch is equivalent to quantitative mismatch. Stroke 2011;42:1010–14

    Abstract/FREE Full Text